arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Kiniksa Pharmaceuticals International, plc

KNSA Health Care Biotechnology: Pharmaceutical Preparations
$48.42
▼ -1.6% Today
as of Jun 7, 07:19 ET
Last 30 days -10.08% Apr 28 → Jun 05
$45.92 $49.56 $53.20 $56.84 $60.48 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$48.98
High
$49.99
Low
$48.21
Volume
$341,611
Avg Vol
$613,735
Mkt Cap
$3.9B
P/E (TTM)
66.33
Beta
52w High
$59.87
52w Low
$26.27
Div Yield
Shares Out

Overview

52-week range
$26
$60
66% of range
Avg surprise (last 1)
+450.0%
Avg reaction (last 1)
+20.5%
100% positive
Latest IV / EM
72%
EM ±9.9% · $50 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.25$-0.12$0.01$0.14$0.27 Actual $0.21Actual $-0.20Actual $-0.25Actual $-0.06Actual $-0.18Actual $0.11Est $0.02Actual $0.23Actual $0.23Actual $0.27 JunSepMarJunSepMar/2025JunSepMar
Revenue vs Net Income Revenue Net income
$-13M$47M$106M$166M$225M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Mar 31, 2026Mar 2026 $0.27 financials
Tue Sep 30, 2025Sep 2025 $0.23 financials
Mon Jun 30, 2025Jun 2025 $0.23 financials
Tue Apr 29, 2025Mar/2025 $0.11 $0.02 +450.0% +20.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.18 financials
Sun Jun 30, 2024Jun 2024 $-0.06 financials
Sun Mar 31, 2024Mar 2024 $-0.25 financials
Sat Sep 30, 2023Sep 2023 $-0.20 financials
Fri Jun 30, 2023Jun 2023 $0.21 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$214M$181M$138M$112M
Cost of revenue$21M$20M$19M$18M$20M$12M
Gross profit
Operating income$29M$24M$20M$13M$-10M$-117,000
Net income$23M$18M$18M$9M$-13M$-4M
EPS (diluted)$0.27$0.23$0.23$0.11$-0.18$-0.06

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$190M$166M$175M$192M$157M$184M$97M$99M
Inventory$73M$55M$41M$48M$22M$26M$29M$35M
Total current assets$594M$527M$476M$420M$356M$332M$311M$301M
Total assets$825M$764M$712M$661M$599M$581M$555M$542M
Long-term debt
Total liabilities$220M$196M$177M$166M$142M$142M$118M$107M
Total equity$606M$568M$535M$495M$457M$438M$437M$435M

Implied volatility — last 90 days

66%69%71%74%76% Jun 07 — IV 72% · EM ±9.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.